Welcome to LookChem.com Sign In|Join Free
  • or
SILDENAFIL HYDROCHLORIDE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

252920-86-8

Post Buying Request

252920-86-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

252920-86-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 252920-86-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,2,9,2 and 0 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 252920-86:
(8*2)+(7*5)+(6*2)+(5*9)+(4*2)+(3*0)+(2*8)+(1*6)=138
138 % 10 = 8
So 252920-86-8 is a valid CAS Registry Number.

252920-86-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-[[3-(4,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulphonyl]-4-methylpiperazine hydrochloride

1.2 Other means of identification

Product number -
Other names sildenafil hydrochloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:252920-86-8 SDS

252920-86-8Upstream product

252920-86-8Downstream Products

252920-86-8Relevant academic research and scientific papers

LIQUID FILLED FORMULATIONS OF PDE5 INHIBITORS

-

Paragraph 074; 075, (2019/05/15)

The instant disclosure provides a composition comprising a capsule and a fill formulation for lipophilic salts of PDE5 inhibitors. Embodiments of the fill formulation contain a liquid, lipid vehicle in which the active ingredient is dissolved and present

PHARMACEUTICALLY ACCEPTABLE SALTS AND POLYMORPHIC FORMS OF SILDENAFIL

-

Page/Page column 23, (2008/06/13)

The present invention is concerned with new pharmaceutically acceptable salts of sildenafil and new polymorphic forms thereof, processes for preparing the new pharmaceutically acceptable salts and new polymorphic forms, pharmaceutical compositions contain

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 252920-86-8